Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females

Abstract

BackgroundCell-free circulating DNA (cfDNA) is becoming a useful biopsy for noninvasive diagnosis of diseases. Microbial sequences in plasma cfDNA may provide important information to improve prognosis and treatment. We have developed a stringent method to identify microbial species via microbial cfDNA in the blood plasma of early-onset breast cancer (EOBC) patients and healthy females. Empirically, microbe-originated sequence reads were identified by mapping non-human PE reads in cfDNA libraries to microbial databases. Those mapped concordantly to unique microbial species were assembled into contigs, which were subsequently aligned to the same databases. Microbial species uniquely aligned were identified and compared across all individuals on MCRPM (Microbial CfDNA Reads Per Million quality PE reads) basis.ResultsThe predominant microbial cfDNAs in all plasma samples examined are originated from bacteria and these bacteria were limited to only a few genera. Among those, Acinetobacter johnsonii XBB1 and low levels of Mycobacterium spp. were commonly found in all healthy females, but also present in an EOBC patient. Compared to those in healthy counterparts, bacterial species in EOBC patients are more diverse and more likely to present at high levels. Among these three EOBC patients tested, a patient who has record high titer (2,724 MCRPM) of Pseudomonas mendocina together with 8.82 MCRPM of Pannonibacter phragmitetus has passed away; another patient infected by multiple Sphingomonas species remains alive; while the third patient who has similar microbial species (Acinetobacter johnsonii XBB1) commonly seen in normal controls is having a normal life.ConclusionsOur preliminary data on the profiles of microbial cfDNA sequences suggested that it may have some prognostic value in cancer patients. Validation in larger number of patients is warranted.

Bacterial DNA induces the formation of heat-resistant disease-associated “Tetz-proteins” in human plasma

“…Our findings suggested a novel role of bacterial eDNA in disease development, and cancer development in particular, consistent with its reported presence in the systemic circulation in association with cancer and other human diseases [20, 82]. Indeed, recent studies have shown that patients with non-infectious early-onset cancer display elevated plasma levels of eDNA from bacteria, particularly Pseudomonas spp.…”

Identification of the plasma total cfDNA level before and after chemotherapy as an indicator of the neoadjuvant chemotherapy response in locally advanced breast cancer

“…Circulating free DNA (cfDNA) is detected in not only patients with cancer but also in healthy individuals . Most of the studies focused on the diagnostic value of cfDNA in early‐stage neoplastic diseases.…”

“…2 Circulating free DNA (cfDNA) is detected in not only patients with cancer but also in healthy individuals. 3 Most of the studies focused on the diagnostic value of cfDNA in early-stage neoplastic diseases. The plasma levels of cfDNA were significantly higher in patients with breast cancer than in patients with benign tumors.…”

Circulating bacterial DNA as a tool towards non-invasive biomarkers for colorectal cancer and adenoma

“…Recently emerging evidences demonstrated the presence of highly divergent bacterial-specific DNA in human blood, though their source of origin is still a mystery to be solved[18, 19, 20]. Huang et al reported that blood bacterial biomarkers had prognostic value for early-onset breast cancer patients[21]. Nevertheless, it is not well understood if any correlation exists between blood microbial DNA and disease progressing in other cancers.…”